Intrinsic Value of S&P & Nasdaq Contact Us

NextCure, Inc. NXTC NASDAQ

NASDAQ Global Select • Healthcare • Biotechnology • US • USD

SharesGrow Score
59/100
4/6 Pass
SharesGrow Intrinsic Value
N/A
Negative cash flow
Analyst Price Target
$15.00
+24.8%

NextCure, Inc. (NXTC) has 20 known insider and institutional holders on record. The largest holder is Sofinnova Venture Partners IX, L.P. with 2,671,856 shares. Other notable holders include Simcere Zaiming, Inc. and Langermann Sol.

Over the last 12 months, insiders have made 13 transactions in NXTC stock — 12 buys (valued at $1.13M) and 0 sells (valued at RSU Award). Insider buying has outpaced selling during this period, which may signal confidence in the company's prospects.

NXTC Insider Ownership

Top Holder
Sofinnova Venture Partners IX, L.P.
2,671,856 shares
Buys (12 mo)
12
$1.13M value
Sells (12 mo)
0
$0.00 value
12-Month Transaction Activity
Buy 92%
Sell 0%
Top Insider Holders
# Name Role Shares Owned Last Filed Relative Size
1 Sofinnova Venture Partners Ix, L.p. 10 Percent Owner 2,671,856 2019-11-19
100%
2 Simcere Zaiming, Inc. 10 Percent Owner 338,636 2025-08-19
13%
3 Langermann Sol Chief Scientific Officer 117,375 2025-02-03
4%
4 Myint Han Chief Medical Officer 93,900 2024-04-02
4%
5 Bingham James B. Chief Development Officer 78,200 2020-03-03
3%
6 Liu Linda Officer 65,600 2022-02-02
2%
7 Richman Michael President & CEO 38,190 2026-02-03
1%
8 Heller Kevin N. Chief Medical Officer 38,119 2020-07-16
1%
9 Kabakoff David S Director 28,050 2025-06-24
1%
10 Shannon Timothy M Director 22,000 2019-06-17
1%
11 Borgman Anne Elizabeth Director 18,700 2025-06-24
1%
12 Houston John G Director 18,700 2025-06-24
1%
13 Feigal Ellen Director 18,700 2025-06-24
1%
14 Webster Stephen W Director 18,700 2025-06-24
1%
15 Jones Elaine V Director 18,700 2025-06-24
1%
16 Guha Udayan Chief Medical Officer 14,670 2026-02-03
1%
17 Mayer Timothy Chief Operating Officer 14,670 2026-02-03
1%
18 Cobourn Steven P. Chief Financial Officer 14,670 2026-02-03
1%
19 Li Judith Director 14,250 2020-06-15
1%
20 Khuong Chau Quang Director 14,250 2023-06-23
1%
Recent Transactions (last 12 months)
Date Name Role Type Shares Price Value
2026-01-30 Guha Udayan Chief Medical Officer RSU Award 14,670 $10.85 $159.17K
2026-01-30 Shaw Kevin G. Sr VP, General Counsel RSU Award 8,270 $10.85 $89.73K
2026-01-30 Kundu Sourav Sr VP, Dev. & Mfg. RSU Award 8,270 $10.85 $89.73K
2026-01-30 Mayer Timothy Chief Operating Officer RSU Award 14,670 $10.85 $159.17K
2026-01-30 Cobourn Steven P. Chief Financial Officer RSU Award 14,670 $10.85 $159.17K
2026-01-30 Richman Michael President & CEO RSU Award 38,190 $10.85 $414.36K
2025-06-20 Simcere Zaiming, Inc. 10 Percent Owner Unknown - - -
2025-06-20 Borgman Anne Elizabeth Director RSU Award 18,700 $0.47 $8.79K
2025-06-20 Feigal Ellen Director RSU Award 18,700 $0.47 $8.79K
2025-06-20 Houston John G Director RSU Award 18,700 $0.47 $8.79K
2025-06-20 Webster Stephen W Director RSU Award 18,700 $0.47 $8.79K
2025-06-20 Jones Elaine V Director RSU Award 18,700 $0.47 $8.79K
2025-06-20 Kabakoff David S Director RSU Award 28,050 $0.47 $13.18K
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
Send us a message